Revolutionary Eye Drops: Say Goodbye to Reading Glasses with PresVu
Mumbai-based Entod Pharmaceuticals launches PresVu Eye Drops, a groundbreaking treatment for presbyopia, promising clear vision for millions.
Presvu Eye DropsEntod PharmaceuticalsPresbyopiaReading GlassesEye CareReal Estate MumbaiSep 04, 2024
Presbyopia, a natural part of aging, typically starts around the mid-40s and progresses until the late 60s, resulting in difficulties focusing on close objects. The good news is that PresVu Eye Drops have been approved by the Drug Controller General of India (DCGI) following a recommendation from the Central Drugs Standard Control Organisation's Subject Expert Committee.
Claimed to be the first eye drop of its kind in India, PresVu is specifically designed for individuals over 40 who want to reduce their reliance on reading glasses. Its proprietary formula not only aims to eliminate the need for eyewear but also lubricates the eyes, enhancing overall comfort.
Frequently Asked Questions
What is Presbyopia?
Presbyopia is a natural part of aging that typically starts around the mid-40s and progresses until the late 60s, resulting in difficulties focusing on close objects.
How does PresVu Eye Drops work?
PresVu Eye Drops use advanced dynamic buffer technology to adapt quickly to tear pH, ensuring consistent performance and safety for long-term use.
Is PresVu Eye Drops available over-the-counter?
No, PresVu Eye Drops are available by prescription only and will be available in pharmacies starting in the first week of October.
How much do PresVu Eye Drops cost?
PresVu Eye Drops will be available at a price of Rs 350, targeting individuals aged 40 to 55 with mild to moderate presbyopia.
Can PresVu Eye Drops enhance near vision quickly?
Yes, according to Dr. Aditya Sethi, PresVu can enhance near vision in as little as 15 minutes.
Related News Articles
Gurugram's Luxury Housing Boom: Ganga Realty Invests ₹1200 Crore in Anantam Project
Ganga Realty's luxury housing project, Anantam, in Gurugram is expected to generate ₹2000 crore in revenue and features 3 and 4 BHK apartments with advanced technologies.
Cabinet Approves Pune Metro Phase 1 Extension for Rs.29.54 Bn
The Union Cabinet has approved the extension of Pune Metro Phase 1, which will cover a distance of 23.3 km and cost Rs.29.54 billion.
Unlocking the Potential of Bajaj Housing Finance IPO with a Single Click
Discover how Bajaj Housing Finance's impressive AUM and market leadership make it an attractive IPO opportunity. Learn more about the one-click IPO feature that simplifies the investment process.
IBLA 2024: DLF's KP Singh: A Legend in the Real Estate Industry
Under KP Singh's guidance, DLF has transformed into a real estate juggernaut with a market capitalization of ₹2,10,426 crore and revenues of ₹6,958 crore. His visionary leadership has set new benchmarks in the industry.
From ₹5000 Crore to ₹10000 Crore: Unpacking Awfis's True Potential
Sometimes, you find yourself drawn to certain companies even before they hit the stock market. For me, Awfis is one of them, and here's why.
Vivek Anand Oberoi: A Visionary Redefining Luxury Real Estate
Vivek Anand Oberoi, a multifaceted entrepreneur, is making waves in the luxury real estate market. Discover how his innovative approach is transforming the industry.